Drug resistance after cessation of efavirenz-based antiretroviral treatment started in pregnancy
Background: To reduce risk of antiretroviral resistance when stopping efavirenz (EFV)-based antiretroviral treatment (ART), staggered discontinuation of antiretrovirals (an NRTI tail) is recommended. However, no data directly support this recommendation. Objectives: We evaluated the prevalence of HI...
Saved in:
Main Authors: | Globahan Ajibola (Author), Christopher Rowley (Author), Dorcas Maruapula (Author), Jean Leidner (Author), Kara Bennett (Author), Kathleen Powis (Author), Roger L. Shapiro (Author), Shahin Lockman (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants
by: Globahan Ajibola, et al.
Published: (2023) -
Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
by: Rebecca Zash, MD, et al.
Published: (2018) -
Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana
by: Kathleen M. Powis, et al.
Published: (2018) -
'Covering the tail' after stopping efavirenz-based antiretroviral therapy
by: Gary Maartens
Published: (2020) -
Efavirenz in pregnancy
by: Polly Clayden, et al.
Published: (2010)